Senior Epidemiologist
Boston Collaborative Drug Surveillance Program
Katrina Wilcox Hagberg is an epidemiologist with a Master of Public Health and over 20 years of clinical reserach and over 15 years of experience in the design, conduct, and analysis of post-marketing drug safety and disease epidemiology studies. She has extensive experience using and validating recorded exposure and diagnosis information in electronic medical records, including use of Clinical Practice Research Datalink GOLD and Aurum and multiple United States medical claims databases. Her prior drug safety work includes cohort and case-control studies evaluating the risk of serious health outcomes with various drug exposures, including cancer, mental health outcomes, cardiovascular disease, venous thrombosis. Two areas of interest include studies where methodological design is used to address confounding by indication and studies on maternal exposures during pregnancy and outcomes in offspring. She has also conducted studies for industry sponsors, including post-marketing safety studies for regulatory agencies.